Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 1Colorectal Neoplasms 1Adenoma 1

Interventions

Radiotherapy, Intensity-Modulated 3Cisplatin 3pembrolizumab 2Metformin 2Laparoscopy 2Gemcitabine 2Capecitabine 2tremelimumab 1sintilimab 1nabiximols 1lenvatinib 1enzalutamide 1durvalumab 1capivasertib 1avelumab 1atezolizumab 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1abiraterone 1Zoledronic Acid 1Trastuzumab 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Rituximab 1Rehabilitation 1Radiotherapy, Conformal 1Radiosurgery 1Radiation Dose Hypofractionation 1Radiation 1Rabeprazole 1Proton Pump Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × OTHER_GOV × Occult Blood × Clear all
NCT01538550 2026-04-14

Pilot Study of a National Screening Programme for Bowel Cancer in Norway

Norwegian Institute of Public Health

Phase NA Active not recruiting
140,000 enrolled
Gastrointestinal

Adenoma, Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡